The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Ben Maimon Carol since year 2005.
The trader's CIK number is 1237252.
At the time of this reporting, Ben Maimon Carol is the President & COO Barr Res of
Barr Pharmaceuticals Inc
(stock ticker symbol BRL).
Stock purchases, sales, and option exercises reported by Ben Maimon Carol since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2006-08-24
BRL
Barr Pharmaceuticals Inc
Option Exercise
2,356
58.36
137,484
2006-08-24
BRL
Barr Pharmaceuticals Inc
Sale
2,300
59.00
135,700
2006-03-03
BRL
Barr Pharmaceuticals Inc
Sale
17,800
67.00
1,192,600
2006-03-01
BRL
Barr Pharmaceuticals Inc
Sale
22,200
66.88
1,484,780
2006-02-22
BRL
Barr Pharmaceuticals Inc
Sale
4,300
67.00
288,100
2006-02-13
BRL
Barr Pharmaceuticals Inc
Sale
25,700
67.00
1,721,900
2006-02-01
BRL
Barr Pharmaceuticals Inc
Sale
20,000
66.08
1,321,639
2006-01-05
BRL
Barr Pharmaceuticals Inc
Sale
41,953
64.26
2,696,067
2006-01-03
BRL
Barr Pharmaceuticals Inc
Sale
19,998
61.63
1,232,516
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Ben Maimon Carol
(President & COO Barr Res of Barr Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
